(0) Write a review
In stock

Tirzepatide 60 Mg

Tirzepatide 60mg Dual Agonist Peptide

$225.00

7 products sold in last 24 hours
41 people are viewing this right now
Buy now
QuantityDiscountPrice
3–58%$207.00
6–910%$202.50
10+12%$198.00
Discount is applied automatically at checkout based on the quantity in your cart.
Ask Us
Product SpecificationTirzepatide 60mg / Lyophilized Powder Vial
Biochemical EngineDual GIP and GLP-1 Receptor Agonist Peptide
Primary Assay TargetInvestigated for synergistic incretin pathway activation, metabolic regulation, and energy homeostasis
Logistics ProfileTemperature-insulated, secure vacuum dispatch with complete tracking

STRICTLY FOR LABORATORY RESEARCH: This synthetic agent is processed strictly for institutional R&D, high-precision in vitro calibrations, and testing lines. Not for human therapeutic or diagnostic use.

Brand:

Description

Tirzepatide 60mg Core Specifications

Deep technical specification parameters optimized for integrating high-mass Tirzepatide into continuous laboratory screening protocols.

Research ParameterAssay Benchmark ProfileInternal Catalog Link
Sequence BlueprintC-Terminal Acylated Polypeptide (Dual-Acting 39 Amino Acid Linear Base)High-Purity Series →
Molecular Weight4813.5 Da (Stabilized with a functional C20 fatty diacid tail chain)
Purity Baseline≥ 98.0% via High-Performance SEC-HPLCMetabolic Series →
Assay TargetSynergistic GIP & GLP-1 Receptor Activation Loops (Zero CNS Shock)

Tirzepatide is a premier synthetic polypeptide architecture explicitly engineered to function as a dual GIP and GLP-1 receptor agonist. By combining Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) helper tracks into a single molecule model, Tirzepatide achieves exceptional metabolic pathway regulation. Featuring a unique C20 lipophilic fatty acid chain modification, this compound extends plasma half-life and delays enzymatic clearance. In modern endocrinology, this high-yield formulation serves as a stable baseline for cell energy adjustments, glucose clearance speed and adipocyte signaling assays. To explore verified research products, visit peptidesk.com for full analytical documentation.

Tirzepatide 60mg Technical Specifications

Technical PropertyLaboratory Standard Specifications
Chemical StructureAcylated 39-Amino Acid Peptide Complex (Dual-Incretin Base)
Active Core Payload60mg Purified Crystalline Powder / Vial (High-Yield Format)
Purity Baseline≥ 98.0% Certified via Tirzepatide HPLC & Mass Spectrometry
Primary Target NodeDual GIPR / GLP-1R activation, lipolysis velocity, & insulinotropic signaling

Research & Compliance Notice: Materials listed as tirzepatide research peptide for sale are supplied strictly for in vitro laboratory profiling, cellular assay design, and scientific research. They are not supplied for human therapeutic use, medical prescriptions, or self-administration.

Tirzepatide Mechanism of Action: GLP-1 & GIP

The core tirzepatide mechanism of action relies on its identity as a tirzepatide dual agonist. Unlike mono-incretin agents, Tirzepatide binds simultaneously to both GIP and GLP-1 receptors across target tissue matrices:

  • GIP Receptor Activation: Directly stimulates GIP receptors on pancreatic beta cells and adipocytes, enhancing glucose-dependent insulin secretion while regulating lipid deposition and metabolic flexibility.
  • GLP-1 Receptor Activation: Binds to GLP-1 cell surface receptors, directing adenylate cyclase pathways to elevate cyclic AMP (cAMP) flux, slowing gastric motility, and signaling hypothalamic satiety centers.
  • Synergistic Metabolic Loop: Co-activation amplifies glucose clearance speed and accelerates fatty acid mobilization without inducing unpredictable cellular stress.

Tirzepatide Core Pathways & Action Matrix

Target PathwayObserved Cellular ActionPrimary Research Goal
Dual Incretin SyncCo-activates GIP and GLP-1 pathways to force steady downstream adenylate cyclase flux.Quantifying cell signaling synergy across metabolic cultures.
Lipid ClearanceStimulates fatty acid mobilization, breaking solid triglyceride blocks inside adipocyte rows.Measuring lipid accumulation deceleration speed.
Transit DecelerationMeasures real-time delay curves in nutrient transit velocities natively across gastric models.Establishing long-term metabolic digestive baselines.

Tirzepatide Weight Loss: Clinical Research & Results

In large-scale trial literature (such as the SURMOUNT clinical trials), tirzepatide for weight loss models demonstrated impressive efficacy. Researchers evaluating tirzepatide weight loss results track several notable parameters:

  • Weight Loss Percentage: Clinical trial data showed an average tirzepatide weight loss percentage exceeding 20% to 22.5% of total body weight over a 72-week research timeline in high-dose maintenance tiers.
  • Metabolic Profile Improvements: Beyond total mass reduction, researchers documented significant improvements in baseline triglycerides, fasting insulin sensitivity, and visceral fat accumulation.
  • High-Yield Assay Applications: Utilizing a 60mg high-yield format allows research facilities to run extended tirzepatide laboratory research and high-throughput multi-well screenings from a single baseline batch.

Tirzepatide vs Mounjaro: What’s the Difference?

When evaluating mounjaro vs tirzepatide or exploring what is tirzepatide in mounjaro, understanding the clinical versus laboratory research context is essential:

AspectMounjaro / ZepboundTirzepatide Research Peptide
Active MoleculeTirzepatide sequence base.Identical Tirzepatide active chemical sequence.
Product FormatPre-filled clinical autoinjector pens.Lyophilized crystalline powder (e.g., 60mg vial).
Primary PurposeFDA-approved clinical treatment for T2D & obesity.In vitro research, receptor binding & cellular assays.

Tirzepatide vs Semaglutide: Weight Loss, Mechanism & Research

In comparative metabolic research, analyzing tirzepatide vs semaglutide (or tirzepatide vs ozempic / wegovy) highlights fundamental mechanical differences between dual and single incretin agonists:

CompoundTarget ReceptorsEfficacy & Research ProfileStructure
Tirzepatide 60mg(Dual Agonist)GIPR + GLP-1RSuperior weight reduction (up to 22.5%) via dual GIP/GLP-1 receptor synergy.39-AA Acylated Peptide
SemaglutideGLP-1R SelectiveSelective GLP-1 agonism achieving ~15% weight reduction in clinical benchmarks.31-AA Acylated Peptide
Orforglipron 6mgGLP-1R (Oral)Non-peptide small molecule evaluated in oral GLP-1 transit models.Small Molecule

Tirzepatide vs Retatrutide: What’s the Difference?

When comparing retatrutide vs tirzepatide in multi-receptor endocrinology trials, researchers evaluate dual versus triple receptor agonism. While Tirzepatide targets GIP and GLP-1 receptors, Retatrutide adds direct Glucagon receptor (GCGR) agonism, driving higher cellular energy expenditure and liver fat oxidation in preclinical models.

Tirzepatide Dosage: Clinical Dose Escalation Explained

Understanding tirzepatide dosing and following a structured dosing schedule is crucial during study protocol designs. Clinical trials utilize a step-wise tirzepatide dose escalation protocol to optimize metabolic tolerance and minimize gastrointestinal friction:

  1. Initiation Phase (Weeks 1–4): Started at a low baseline dose of 2.5mg weekly to allow receptor acclimation.
  2. Step-Up Titration (Weeks 5–8+): Escalated in 2.5mg increments every 4 weeks (moving through 5mg, 7.5mg, 10mg, and 12.5mg).
  3. Top Maintenance Tier (15mg Weekly): Top clinical maintenance doses reach 15mg once weekly, offering maximum dual-incretin activation.

Tirzepatide Side Effects & Safety

Documenting tirzepatide side effects and monitoring safety profiles is a core part of laboratory trial administration. Secondary observations recorded in trial literature include:

  • Gastrointestinal Responses: Transient tirzepatide nausea, mild vomiting,  diarrhea, tirzepatide constipation, or abdominal discomfort during early titration steps.
  • Systemic Observations: Mild tirzepatide fatigue, light headaches, or temporary appetite suppression. Secondary hair loss (telogen effluvium) or lean muscle loss may occur secondary to rapid calorie deficit transitions.
  • Mitigation via Titration: Adhering to gradual dose escalation significantly reduces gastrointestinal adverse effects across test cohorts.

Storage & Reconstitution Guidelines

  • FREEZER (-20°C)
    Lyophilized Powder: Store dry crystalline powder vials inside a laboratory freezer at -20°C to -80°C for long-term storage up to 24 months.
  • TRANSIT WINDOW
    Unreconstituted Powder: Resilient to room temperature transport up to 25°C for up to 3 weeks. Return to freezer storage upon arrival.
  • REFRIGERATOR (2°C – 8°C)
    Reconstituted Fluid Phase: Keep liquid solutions stored under laboratory refrigeration between 2°C and 8°C. Exhaust active liquid within 10 to 14 days. Do not refreeze liquid.

Step-by-Step Reconstitution Protocol

  1. Allow the 60mg vial to naturally reach room temperature before removing the flip-off cap.
  2. Cleanse the top entry rubber stopper with a sterile isopropyl alcohol wipe.
  3. Slowly introduce sterile bacteriostatic water, letting fluid cascade down the inside glass wall to prevent mechanical shock.
  4. Do not shake. Gently swirl the vial in circular concentric movements until dissolved into a clear liquid.

Analytical Verification & Lab Reports: Inspect our latest batch-specific HPLC purity charts, mass spectrometry results, and independent Certificate of Analysis (COA) documents directly on our PeptidesK Third-Party Lab Testing Page.

To buy tirzepatide research peptide or source verified tirzepatide 60mg vials for sale backed by high HPLC purity and fast domestic delivery, order directly from peptidesk.com.

Shop by Goal Categories

Explore our high-purity research compounds and peptides categorized by primary experimental targets and research goals:

Goal CategoryPrimary Research Focus
Anti-Aging & Longevity Peptides →Cellular renewal, telomere maintenance, and anti-senescence research models.
Fat Loss & Metabolic Peptides →Incretin mimetics, lipolysis acceleration, and metabolic flexibility profiling.
Muscle Growth & Building Peptides →Anabolic signaling, GH secretagogues, and protein synthesis acceleration.
Recovery & Healing Peptides →Soft tissue repair, tendon-to-bone recovery, and systemic cell migration.
Focus & Cognitive Peptides →Nootropic signaling, neuroprotection, and synaptic plasticity assays.

Why Buy PeptidesK Tirzepatide 60mg Online?

Why Buy PeptidesK Tirzepatide 60mg Online?

In metabolic research examining dual-action receptor pathways, securing reference compounds with high chemical stability and verified sequence fidelity is crucial. PeptidesK Tirzepatide 60mg offers scientific researchers a high-concentration dual GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist engineered for consistent analytical performance in vitro.

At PeptidesK, we enforce stringent quality control across all inventory batches. Every lot of Tirzepatide 60mg undergoes independent third-party laboratory verification to confirm exact dosing, molecular weight, and high chemical purity. Sourcing reference materials from PeptidesK ensures your laboratory receives pure, reliable compounds free from batch-to-batch variation.

Purchasing research peptides online through PeptidesK provides unmatched security, speed, and convenience:

  • ✔ HPLC & MS Certified Purity: Independent Certificates of Analysis (CoA) available for full analytical transparency.
  • ✔ Rapid & Secure Shipping: Express worldwide dispatch in temperature-protected packaging to safeguard stability.
  • ✔ Client Benefits & Support: 24/7 dedicated support team alongside exclusive crypto payment discounts.

Elevate your metabolic research standards today—order standard-grade Tirzepatide 60mg directly from PeptidesK for swift delivery and guaranteed quality.

Frequently Asked Questions (FAQ)

1. What is Tirzepatide 60mg and how does it function?

Tirzepatide is a synthetic peptide engineered as a dual GIP and GLP-1 receptor agonist. In preclinical research, it is studied for its synergistic activation of metabolic pathways, insulin secretion signaling, and energy homeostasis mechanisms.

2. Why choose PeptidesK over other peptide vendors?

PeptidesK ensures third-party lab-verified purity reports, transparent CoA documentation, rapid order processing, and encrypted checkout, offering research-grade chemicals tailored for scientific accuracy.

3. How should Tirzepatide 60mg be stored in the lab?

Keep lyophilized Tirzepatide sealed in a dry, cool environment protected from light. For optimal long-term shelf stability, store the product in a refrigerated setting between 2°C and 8°C.

4. Are Third-Party Certificates of Analysis (CoA) available?

Yes. Every lot of Tirzepatide 60mg supplied by PeptidesK includes verified High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) test results to confirm chemical purity.

5. What are the shipping timelines and packaging safety?

Orders are dispatched within 24–48 hours using express shipping methods. All shipments feature discreet, protective packaging designed to preserve chemical integrity during transport.

6. Is Tirzepatide 60mg intended for human consumption?

No. All items available on PeptidesK, including Tirzepatide 60mg, are strictly intended for laboratory, in-vitro, and scientific research purposes. They are not designed or sold for human or clinical use.

Reviews

Be the first to review “Tirzepatide 60 Mg”

Your email address will not be published. Required fields are marked *

There are no reviews yet.

Search

Back to Top
Product has been added to your cart
Compare (0)